JP2016518399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016518399A5 JP2016518399A5 JP2016512427A JP2016512427A JP2016518399A5 JP 2016518399 A5 JP2016518399 A5 JP 2016518399A5 JP 2016512427 A JP2016512427 A JP 2016512427A JP 2016512427 A JP2016512427 A JP 2016512427A JP 2016518399 A5 JP2016518399 A5 JP 2016518399A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- hydroxy
- benzamide
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201308409A GB201308409D0 (en) | 2013-05-10 | 2013-05-10 | Compounds |
| GB1308409.0 | 2013-05-10 | ||
| GB201315253A GB201315253D0 (en) | 2013-08-28 | 2013-08-28 | Compounds |
| GB1315253.3 | 2013-08-28 | ||
| PCT/GB2014/051454 WO2014181137A1 (en) | 2013-05-10 | 2014-05-12 | Novel histone deacetylase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019015446A Division JP2019077721A (ja) | 2013-05-10 | 2019-01-31 | 新規ヒストンデアセチラーゼインヒビター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016518399A JP2016518399A (ja) | 2016-06-23 |
| JP2016518399A5 true JP2016518399A5 (enExample) | 2017-03-16 |
| JP6513078B2 JP6513078B2 (ja) | 2019-05-15 |
Family
ID=50736120
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016512427A Expired - Fee Related JP6513078B2 (ja) | 2013-05-10 | 2014-05-12 | 新規ヒストンデアセチラーゼインヒビター |
| JP2019015446A Withdrawn JP2019077721A (ja) | 2013-05-10 | 2019-01-31 | 新規ヒストンデアセチラーゼインヒビター |
| JP2020103565A Pending JP2020158523A (ja) | 2013-05-10 | 2020-06-16 | 新規ヒストンデアセチラーゼインヒビター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019015446A Withdrawn JP2019077721A (ja) | 2013-05-10 | 2019-01-31 | 新規ヒストンデアセチラーゼインヒビター |
| JP2020103565A Pending JP2020158523A (ja) | 2013-05-10 | 2020-06-16 | 新規ヒストンデアセチラーゼインヒビター |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9862685B2 (enExample) |
| EP (1) | EP2994465B1 (enExample) |
| JP (3) | JP6513078B2 (enExample) |
| KR (1) | KR20160007577A (enExample) |
| CN (1) | CN105358550B (enExample) |
| AU (1) | AU2014264370B2 (enExample) |
| BR (1) | BR112015028215A2 (enExample) |
| CA (1) | CA2911856A1 (enExample) |
| CY (1) | CY1120705T1 (enExample) |
| DK (1) | DK2994465T3 (enExample) |
| ES (1) | ES2688815T3 (enExample) |
| HR (1) | HRP20181381T1 (enExample) |
| HU (1) | HUE039690T2 (enExample) |
| IL (1) | IL242388B (enExample) |
| LT (1) | LT2994465T (enExample) |
| MX (1) | MX373196B (enExample) |
| NZ (1) | NZ714283A (enExample) |
| PL (1) | PL2994465T3 (enExample) |
| PT (1) | PT2994465T (enExample) |
| RS (1) | RS57816B1 (enExample) |
| SG (1) | SG11201509174UA (enExample) |
| SI (1) | SI2994465T1 (enExample) |
| SM (1) | SMT201800501T1 (enExample) |
| WO (1) | WO2014181137A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2391605B1 (en) | 2009-01-28 | 2017-11-08 | Karus Therapeutics Limited | Scriptaid isosteres and their use in therapy |
| BR112012003955A2 (pt) | 2009-08-20 | 2017-09-26 | Karus Therapeutics Ltd | compostos heterocíclicos tricíclicos como inibidores da fosfoinositídeos 3-quinase |
| GB201204125D0 (en) | 2012-03-08 | 2012-04-25 | Karus Therapeutics Ltd | Compounds |
| US9676765B2 (en) | 2012-11-07 | 2017-06-13 | Karus Therapeutics Limited | Histone deacetylase inhibitors and their use in therapy |
| WO2017156493A1 (en) | 2016-03-11 | 2017-09-14 | Denali Therapeutics Inc. | Compounds, compositions, and methods |
| NZ714283A (en) | 2013-05-10 | 2020-04-24 | Karus Therapeutics Ltd | Novel histone deacetylase inhibitors |
| GB201402431D0 (en) | 2014-02-12 | 2014-03-26 | Karus Therapeutics Ltd | Compounds |
| GB201419228D0 (en) | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
| GB201419264D0 (en) * | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
| GB201514751D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compounds |
| GB201514760D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compounds and method of use |
| GB201514758D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Formulation |
| GB201514754D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compounds |
| GB201514756D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compound and method of use |
| US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| TWI659949B (zh) * | 2016-05-16 | 2019-05-21 | 臺北醫學大學 | 組蛋白去乙醯酶6抑制劑及其用途 |
| GB201609786D0 (en) * | 2016-06-03 | 2016-07-20 | Karus Therapeutics Ltd | Compounds and method of use |
| IL299415B2 (en) | 2016-06-16 | 2025-09-01 | Denali Therapeutics Inc | Pyrimidine-2-ylamino-1H-pyrazoles as LRRK2 inhibitors for use in the treatment of neurodegenerative disorders |
| KR102556214B1 (ko) * | 2016-07-08 | 2023-07-19 | 주식회사유한양행 | 벤조[d]싸이아졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물 |
| JP7068297B2 (ja) * | 2016-11-10 | 2022-05-16 | アセチロン ファーマシューティカルズ インコーポレイテッド | フェニル及びピリジニルヒドロキサム酸 |
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| AU2018258338B2 (en) * | 2017-04-26 | 2022-07-14 | The Board Of Trustees Of The University Of Illinois | Nrf and HIF activators/HDAC inhibitors and therapeutic methods using the same |
| GB201803361D0 (en) * | 2018-03-01 | 2018-04-18 | Karus Therapeutics Ltd | Histone deacetylase inhibitors |
| KR102328682B1 (ko) | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
| EP3876930A4 (en) | 2018-11-07 | 2022-07-20 | Dana-Farber Cancer Institute, Inc. | BENZIMIDAZOLE DERIVATIVES AND AZA-BENZIMIDAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND THEIR USES |
| EP3877371A4 (en) | 2018-11-07 | 2022-07-27 | Dana-Farber Cancer Institute, Inc. | IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES USED AS JANUS KINASE 2 INHIBITORS AND ASSOCIATED USES |
| US12415816B2 (en) | 2018-11-07 | 2025-09-16 | Dana-Farber Cancer Institute, Inc. | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof |
| CA3144985A1 (en) | 2019-06-27 | 2020-12-30 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Hdac6-activated macrophages, compositions, and uses thereof |
| GB201909466D0 (en) * | 2019-07-01 | 2019-08-14 | Karus Therapeutics Ltd | Compounds for treating cancer |
| WO2021067859A1 (en) * | 2019-10-03 | 2021-04-08 | Tenaya Therapeutics, Inc. | 5-fluoronicotinamide derivatives and uses thereof |
| MX2022007376A (es) | 2019-12-20 | 2022-09-02 | Tenaya Therapeutics Inc | Fluoroalqull-oxadiazoles y sus usos. |
| WO2021226261A1 (en) | 2020-05-06 | 2021-11-11 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| EP4267574B1 (en) | 2020-12-23 | 2025-04-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| TW202308619A (zh) | 2021-05-04 | 2023-03-01 | 美商特納亞治療股份有限公司 | 用於治療代謝疾病和hfpef的hdac6抑制劑 |
| JP2024524373A (ja) | 2021-06-28 | 2024-07-05 | ブループリント メディシンズ コーポレイション | Ｃｄｋ２阻害剤 |
| WO2023086320A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
| JP7782035B2 (ja) | 2021-11-09 | 2025-12-08 | エイジャックス セラピューティクス， インコーポレイテッド | Ｊａｋ２阻害剤としての６－ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール |
| AU2024234668A1 (en) * | 2023-03-14 | 2025-09-25 | Miralinc Pharma, Inc. | Heterocyclic compounds as selective hdac6 inhibitors |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4017500A (en) | 1973-07-16 | 1977-04-12 | Schering Corporation | Certain 8-amino-1,7-naphthyridines |
| DE2908324A1 (de) | 1979-03-03 | 1980-09-18 | Hoechst Ag | Triazolsubstituierte hydratopasaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschutzmittel |
| US4792562A (en) | 1985-12-04 | 1988-12-20 | Hoechst-Roussel Pharmaceuticals, Inc. | N-(pyrrol-1-yl)pyridinamines having memory enhancing activity |
| JPH0532662A (ja) | 1990-11-09 | 1993-02-09 | Nissan Chem Ind Ltd | 置換ピラゾール誘導体および農園芸用殺菌剤 |
| US5214038A (en) | 1991-04-15 | 1993-05-25 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof |
| DE4120107A1 (de) | 1991-06-14 | 1992-12-17 | Schering Ag | Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole |
| TW343965B (en) | 1994-03-30 | 1998-11-01 | Hoffmann La Roche | Novel mono- and bicyclic DNA gyrase inhibitors |
| JP2000511883A (ja) | 1996-04-19 | 2000-09-12 | ノボ ノルディスク アクティーゼルスカブ | ホスホチロシン認識ユニットを有する分子のモジュレーター |
| EP0887348A1 (en) | 1997-06-25 | 1998-12-30 | Boehringer Mannheim Italia S.p.A. | Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
| JP3712529B2 (ja) | 1998-04-24 | 2005-11-02 | 大鵬薬品工業株式会社 | ３，３−ジピリジルアクリル酸アミド誘導体又はその薬学的に許容される塩 |
| AU769864B2 (en) | 1999-02-12 | 2004-02-05 | Hoya Corporation | Eyeglass and its manufacturing method |
| EP1189609A4 (en) | 1999-05-03 | 2002-10-30 | Smithkline Beecham Corp | CXCR-4 RECEPTOR ANTAGONISTS AND THROMBOPOIETIN MIMETIKA |
| JP5278983B2 (ja) | 1999-11-17 | 2013-09-04 | 塩野義製薬株式会社 | アミド化合物の新規用途 |
| GB9929988D0 (en) | 1999-12-17 | 2000-02-09 | Celltech Therapeutics Ltd | Chemical compounds |
| US6608053B2 (en) | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| CN1186324C (zh) | 2000-04-27 | 2005-01-26 | 山之内制药株式会社 | 稠合杂芳基衍生物 |
| AU2001270260A1 (en) | 2000-06-30 | 2002-01-14 | Sugen, Inc. | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| JP2004512336A (ja) * | 2000-09-15 | 2004-04-22 | アノーメッド インコーポレイティド | ケモカインレセプター結合複素環式化合物 |
| JP2002255964A (ja) | 2000-10-24 | 2002-09-11 | Sankyo Co Ltd | イミダゾピリジン誘導体 |
| WO2002034748A1 (fr) | 2000-10-24 | 2002-05-02 | Sankyo Company, Limited | Derives d'imidazopyridine |
| US6905669B2 (en) | 2001-04-24 | 2005-06-14 | Supergen, Inc. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| US7429593B2 (en) | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| ES2322950T3 (es) * | 2002-03-13 | 2009-07-02 | Janssen Pharmaceutica Nv | Derivados de aminocarbonilo como nuevos inhibidores de histona-desacetilasa. |
| JP2003313126A (ja) | 2002-04-23 | 2003-11-06 | Sankyo Co Ltd | イミダゾピリジン誘導体を有効成分とする医薬 |
| JP2004002826A (ja) | 2002-04-24 | 2004-01-08 | Sankyo Co Ltd | 高分子イミダゾピリジン誘導体 |
| JP4235726B2 (ja) | 2002-11-19 | 2009-03-11 | 国立大学法人 奈良先端科学技術大学院大学 | 大きな二光子吸収特性を示すアセチレン結合により連結されたビス（イミダゾリルポルフィリン金属錯体）を構成単位とするポルフィリン連鎖体及びその製造方法 |
| AU2003900608A0 (en) | 2003-02-11 | 2003-02-27 | Fujisawa Pharmaceutical Co., Ltd. | Hdac inhibitor |
| EP1724267B1 (en) | 2004-02-26 | 2013-11-06 | ASKA Pharmaceutical Co., Ltd. | Pyrimidine derivative |
| MXPA06014018A (es) | 2004-06-01 | 2007-02-08 | Hoffmann La Roche | 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas. |
| US20090110720A1 (en) | 2004-10-06 | 2009-04-30 | Anders Nykjaer | Use of compounds for the prevention of drug-induced cell toxicity |
| GB0423653D0 (en) | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
| JP2008530136A (ja) * | 2005-02-14 | 2008-08-07 | ミイカナ セラピューティクス インコーポレイテッド | ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物 |
| EP2491926B1 (en) | 2005-03-22 | 2018-05-09 | President and Fellows of Harvard College | Treatment of protein degradation disorders |
| JP2008545660A (ja) | 2005-05-20 | 2008-12-18 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼ阻害剤として有用なピロロピリジン化合物 |
| TW200716545A (en) | 2005-06-10 | 2007-05-01 | Sigma Tau Ind Farmaceuti | Indole derivatives having anti-tumor activity |
| WO2007050348A2 (en) | 2005-10-21 | 2007-05-03 | Merck & Co., Inc. | Potassium channel inhibitors |
| WO2007084667A2 (en) | 2006-01-19 | 2007-07-26 | Osi Pharmaceutical, Inc. | Fused heterobicyclic kinase inhibitors |
| WO2007085540A1 (en) | 2006-01-27 | 2007-08-02 | Glaxo Group Limited | 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives |
| CN101511840A (zh) | 2006-04-26 | 2009-08-19 | 吉宁特有限公司 | 磷酸肌醇3-激酶抑制剂化合物及其使用方法 |
| JP5302186B2 (ja) | 2006-04-26 | 2013-10-02 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐｉ３ｋ阻害剤としてのピリミジン誘導体 |
| WO2008007780A1 (fr) | 2006-07-13 | 2008-01-17 | Kyowa Hakko Kirin Co., Ltd. | Dérivé du pentadiènamide |
| CN101534831B (zh) | 2006-09-11 | 2013-07-17 | 柯瑞斯公司 | 包含锌结合基团的取代的酪氨酸抑制剂 |
| ES2532899T3 (es) | 2006-10-28 | 2015-04-01 | Methylgene Inc. | Derivados de dibenzo[b,f][1,4]oxazepina como inhibidores de histona desacetilasa |
| JP5178731B2 (ja) | 2006-11-22 | 2013-04-10 | カルス セラピューティクス リミテッド | デプシペプチドおよびその治療的使用 |
| CN101663276A (zh) | 2007-01-31 | 2010-03-03 | 沃泰克斯药物股份有限公司 | 用作激酶抑制剂的2-氨基吡啶衍生物 |
| JP2010518014A (ja) | 2007-01-31 | 2010-05-27 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用な２−アミノピリジン誘導体 |
| WO2008122115A1 (en) | 2007-04-09 | 2008-10-16 | Methylgene Inc. | Inhibitors of histone deacetylase |
| WO2008139987A1 (ja) | 2007-04-26 | 2008-11-20 | Japan Science And Technology Agency | Ｇタンパク質共役型レセプタ－作動剤 |
| WO2008137270A1 (en) | 2007-05-04 | 2008-11-13 | H. Lundbeck A/S | Methods of diagnosing and monitoring of npy y5 based disorders |
| EP2154965A4 (en) | 2007-05-29 | 2011-08-17 | Glaxosmithkline Llc | NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS |
| GB0710528D0 (en) | 2007-06-01 | 2007-07-11 | Glaxo Group Ltd | Novel compounds |
| WO2009063240A1 (en) | 2007-11-16 | 2009-05-22 | Arrow Therapeutics Limited | 2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase |
| WO2009137462A2 (en) * | 2008-05-05 | 2009-11-12 | Envivo Pharmaceuticals, Inc. | Methods for treating cognitive disorders using inhibitors of histone deacetylase |
| JP2011529932A (ja) | 2008-08-05 | 2011-12-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ナフチリジン及び医薬としてのその使用 |
| US20110257170A1 (en) | 2008-10-03 | 2011-10-20 | Merck Serono Sa | 4-morpholino-pyrido[3,2-d]pyrimidines |
| GB2465405A (en) | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| EP2391605B1 (en) | 2009-01-28 | 2017-11-08 | Karus Therapeutics Limited | Scriptaid isosteres and their use in therapy |
| US8431538B2 (en) | 2009-07-22 | 2013-04-30 | The Board Of Trustees Of The University Of Illinois | HDAC inhibitors and therapeutic methods of using same |
| BR112012003955A2 (pt) | 2009-08-20 | 2017-09-26 | Karus Therapeutics Ltd | compostos heterocíclicos tricíclicos como inibidores da fosfoinositídeos 3-quinase |
| GB201007347D0 (en) | 2010-04-30 | 2010-06-16 | Karus Therapeutics Ltd | Compounds |
| ES2647368T3 (es) | 2010-10-08 | 2017-12-21 | Vib Vzw | Inhibidores de HDAC para tratar la enfermedad de Charcot-Marie-Tooth |
| AR084312A1 (es) | 2010-12-16 | 2013-05-08 | Genentech Inc | Compuestos triciclicos inhibidores de la pi3k y composiciones farmaceuticas |
| CA2825599C (en) * | 2011-02-01 | 2021-07-13 | The Board Of Trustees Of The University Of Illinois | 4-methyl-n-hydroxybenzamide compounds as histone deacetylase (hdac) inhibitors |
| EP2508510A1 (en) | 2011-04-06 | 2012-10-10 | Ikerchem, S.L. | Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof |
| JP6169076B2 (ja) | 2011-07-20 | 2017-07-26 | ザ ジェネラル ホスピタル コーポレイション | 骨疾患の処置のためのヒストン脱アセチル化酵素６選択的阻害剤 |
| CA2850757A1 (en) | 2011-10-03 | 2013-04-11 | The Trustees Of Columbia University In The City Of New York | Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1 |
| PH12014500724A1 (en) | 2011-10-04 | 2014-05-19 | Institute For Hepatitis And Virus Res | Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication |
| KR20130047623A (ko) * | 2011-10-28 | 2013-05-08 | 주식회사종근당 | 신규한 선택적인 히스톤탈아세틸화 효소 억제제로서의 하이드록사메이트 유도체 및 이를 포함하는 약제학적 조성물 |
| EP2790705B1 (en) | 2011-12-15 | 2017-12-06 | Novartis AG | Use of inhibitors of the activity or function of pi3k |
| KR101415742B1 (ko) | 2011-12-21 | 2014-07-04 | 영남대학교 산학협력단 | 6―아미노피리딘―3―올 유도체 또는 이의 약제학적 허용가능한 염 및 이를 유효성분으로 함유하는 혈관신생으로 인한 질환의 예방 또는 치료용 약학조성물 |
| GB201204125D0 (en) | 2012-03-08 | 2012-04-25 | Karus Therapeutics Ltd | Compounds |
| WO2014032019A2 (en) | 2012-08-23 | 2014-02-27 | Georgetown University | Compounds and methods of use thereof for treating tumors |
| US9676765B2 (en) | 2012-11-07 | 2017-06-13 | Karus Therapeutics Limited | Histone deacetylase inhibitors and their use in therapy |
| CA2889905A1 (en) | 2012-11-08 | 2014-05-15 | Rhizen Pharmaceuticals Sa | Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase inhibitor |
| US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| KR20150130314A (ko) * | 2013-03-13 | 2015-11-23 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 전체 게놈의 신속한 맵핑을 위한 나노유체 장치 및 관련 시스템 및 분석 방법 |
| US20160052926A1 (en) | 2013-03-15 | 2016-02-25 | Hutchison Medipharma Limited | Novel pyrimidine and pyridine compounds and usage thereof |
| WO2014153280A1 (en) | 2013-03-22 | 2014-09-25 | Merck Sharp & Dohme Corp. | 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors |
| NZ714283A (en) | 2013-05-10 | 2020-04-24 | Karus Therapeutics Ltd | Novel histone deacetylase inhibitors |
| US20150105383A1 (en) | 2013-10-10 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma |
| GB201402431D0 (en) | 2014-02-12 | 2014-03-26 | Karus Therapeutics Ltd | Compounds |
| JP6556146B2 (ja) | 2014-08-26 | 2019-08-07 | 武田薬品工業株式会社 | 複素環化合物 |
| GB201419264D0 (en) | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
| GB201419228D0 (en) | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
| GB201514756D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compound and method of use |
| GB201609786D0 (en) | 2016-06-03 | 2016-07-20 | Karus Therapeutics Ltd | Compounds and method of use |
| WO2017222952A1 (en) | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| EP3475275B1 (en) | 2016-06-23 | 2024-04-10 | Merck Sharp & Dohme LLC | 3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| WO2017222950A1 (en) | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3-heterocyclyl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| GB201803361D0 (en) | 2018-03-01 | 2018-04-18 | Karus Therapeutics Ltd | Histone deacetylase inhibitors |
-
2014
- 2014-05-12 NZ NZ714283A patent/NZ714283A/en not_active IP Right Cessation
- 2014-05-12 JP JP2016512427A patent/JP6513078B2/ja not_active Expired - Fee Related
- 2014-05-12 PL PL14725240T patent/PL2994465T3/pl unknown
- 2014-05-12 ES ES14725240.7T patent/ES2688815T3/es active Active
- 2014-05-12 CN CN201480035628.3A patent/CN105358550B/zh not_active Expired - Fee Related
- 2014-05-12 KR KR1020157034809A patent/KR20160007577A/ko not_active Abandoned
- 2014-05-12 HR HRP20181381TT patent/HRP20181381T1/hr unknown
- 2014-05-12 WO PCT/GB2014/051454 patent/WO2014181137A1/en not_active Ceased
- 2014-05-12 SM SM20180501T patent/SMT201800501T1/it unknown
- 2014-05-12 LT LTEP14725240.7T patent/LT2994465T/lt unknown
- 2014-05-12 CA CA2911856A patent/CA2911856A1/en not_active Abandoned
- 2014-05-12 BR BR112015028215A patent/BR112015028215A2/pt not_active IP Right Cessation
- 2014-05-12 RS RS20181097A patent/RS57816B1/sr unknown
- 2014-05-12 HU HUE14725240A patent/HUE039690T2/hu unknown
- 2014-05-12 PT PT14725240T patent/PT2994465T/pt unknown
- 2014-05-12 SI SI201430874T patent/SI2994465T1/sl unknown
- 2014-05-12 US US14/890,331 patent/US9862685B2/en not_active Expired - Fee Related
- 2014-05-12 MX MX2015015450A patent/MX373196B/es active IP Right Grant
- 2014-05-12 DK DK14725240.7T patent/DK2994465T3/en active
- 2014-05-12 AU AU2014264370A patent/AU2014264370B2/en not_active Ceased
- 2014-05-12 EP EP14725240.7A patent/EP2994465B1/en active Active
- 2014-05-12 SG SG11201509174UA patent/SG11201509174UA/en unknown
-
2015
- 2015-11-01 IL IL242388A patent/IL242388B/en active IP Right Grant
-
2017
- 2017-08-02 US US15/667,069 patent/US10870624B2/en not_active Expired - Fee Related
-
2018
- 2018-09-18 CY CY181100964T patent/CY1120705T1/el unknown
-
2019
- 2019-01-31 JP JP2019015446A patent/JP2019077721A/ja not_active Withdrawn
-
2020
- 2020-06-16 JP JP2020103565A patent/JP2020158523A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016518399A5 (enExample) | ||
| AU2012356374B2 (en) | Pyridinone and pyrimidinone derivatives as factor XIa inhibitors | |
| ES2625744T3 (es) | Imidazo[1,2-a]piridinas sustituidas con 3-arilo y su uso | |
| AU2016263564B2 (en) | Triazole agonists of the APJ receptor | |
| DK2164843T3 (en) | pyridazinone | |
| US10428044B2 (en) | 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones | |
| JP2021504443A5 (enExample) | ||
| JP2009534386A (ja) | Ｍｅｋインヒビターとしての新規ヘテロアリール置換アリールアミノピリジン誘導体 | |
| AU2018316587A1 (en) | Pyruvate kinase activators for use in treating blood disorders | |
| JP2017512786A (ja) | ＴｒｋＡキナーゼ阻害薬、その組成物および方法 | |
| JP2010513272A5 (enExample) | ||
| JP2015535273A5 (enExample) | ||
| AU2007293373A1 (en) | Inhibitors of 5 -lipoxygenase activating protein (FLAP) | |
| JP2011503230A5 (enExample) | ||
| JP2018506571A (ja) | Ｒｈｏ関連プロテインキナーゼの阻害及び疾患の治療のためのインダゾリルチアジアゾールアミン及び関連する化合物 | |
| JP2017500364A5 (enExample) | ||
| JP2017532357A5 (enExample) | ||
| JP2017532358A5 (enExample) | ||
| JP2017519818A5 (enExample) | ||
| JP6329958B2 (ja) | 新規ヒストンデアセチラーゼインヒビターおよび治療におけるその使用 | |
| AU2023261964A1 (en) | Compounds for inhibiting kif18a | |
| JP2015524483A5 (enExample) | ||
| AU2019346028B2 (en) | Novel compounds as NADPH Oxidase inhibitors | |
| IL322435A (en) | Covalent modifiers of Akt1 and their uses | |
| JP2014510147A5 (enExample) |